Skip to content

A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco

A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01509586
Enrollment
1236
Registered
2012-01-13
Start date
2011-11-30
Completion date
2016-03-31
Last updated
2023-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking Cessation

Keywords

smoking, smoking cessation, Potentially Reduced Exposure Products (PREPs)

Brief summary

This nationwide telephone and mail- based research study will recruit 1,400 cigarette smokers who are not motivated to quit to test the effects of a marketed oral, non-combustible smokeless tobacco product on cigarette smoking behaviors. It will also track the participants' usage patterns of the smokeless tobacco product. Half of the participants will receive a new, potentially safer tobacco product during the first six weeks of the study, and half will not. During this six-week period, each participant will complete three brief phone interviews. After this first six week period, participants will complete 6 other brief follow-up interviews, where they will answer questionnaires about their smoking habits.

Interventions

DRUGPotentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product

The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>=19 * a daily cigarette smoker of \>=10 cigs/day * English speaking * live in the contiguous U.S. * unmotivated to quit smoking in the next 30 days

Exclusion criteria

* no use of smokeless tobacco in past six months * not breastfeeding, pregnant, or planning a pregnancy * devoid of any recent (past 6 months) cardiovascular trauma * no quit attempt of \>=1 week in past 6 months * no use of pharmacotherapy to quit smoking in past 3 months

Design outcomes

Primary

MeasureTime frameDescription
Quit Attempts and AbstinenceFrom study enrollment through end of one-year follow up% of study participants making a quit attempt or staying abstinent from smoking during the study Notes: Floating abstinence: Any 7-day period of non-smoking, ever within study. PPA: point-prevalence abstinence

Countries

United States

Participant flow

Participants by arm

ArmCount
PREP (Potentially Reduced Exposure Product) Group
Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product: The PREP Group will be given a sample supply of a PREP product that is already on the market. It is unclear if it is safer than cigarettes, and that is why it is classified as a Potentially Reduced Exposure Product. It provides both nicotine and tobacco in the form of a pouch that can be thrown away after used. Unlike chewing tobacco, there is no need for spitting with this product. There are multiple flavors and participants will have his/her choice of preferred flavor. This group will be asked to sample the product and use it in several ways, but whether a participant uses the product or not is up him/her.
626
Cigarette Group
This group will smoke their normal cigarettes as much or as little as they want to.
610
Total1,236

Baseline characteristics

CharacteristicPREP (Potentially Reduced Exposure Product) GroupCigarette GroupTotal
Age, Continuous48.7 years
STANDARD_DEVIATION 12.5
48.7 years
STANDARD_DEVIATION 12.6
48.7 years
STANDARD_DEVIATION 12.6
Cigarettes per day20.1 average cigarettes per day at baseline
STANDARD_DEVIATION 8.7
19.9 average cigarettes per day at baseline
STANDARD_DEVIATION 8.4
20.0 average cigarettes per day at baseline
STANDARD_DEVIATION 8.6
Confidence to quit smoking2.6 units on a scale
STANDARD_DEVIATION 3.1
2.7 units on a scale
STANDARD_DEVIATION 3
2.7 units on a scale
STANDARD_DEVIATION 3.1
Intend to quit smoking, next month1.4 units on a scale
STANDARD_DEVIATION 2.3
1.3 units on a scale
STANDARD_DEVIATION 2.4
1.4 units on a scale
STANDARD_DEVIATION 2.4
Race/Ethnicity, Customized
African-American
56 participants61 participants117 participants
Race/Ethnicity, Customized
Caucasian
557 participants531 participants1088 participants
Race/Ethnicity, Customized
Other
13 participants18 participants31 participants
Sex: Female, Male
Female
438 Participants397 Participants835 Participants
Sex: Female, Male
Male
188 Participants213 Participants401 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
458 / 626414 / 610
serious
Total, serious adverse events
3 / 6263 / 610

Outcome results

Primary

Quit Attempts and Abstinence

% of study participants making a quit attempt or staying abstinent from smoking during the study Notes: Floating abstinence: Any 7-day period of non-smoking, ever within study. PPA: point-prevalence abstinence

Time frame: From study enrollment through end of one-year follow up

ArmMeasureGroupValue (NUMBER)
PREP (Potentially Reduced Exposure Product) GroupQuit Attempts and AbstinenceWeek 58 PPA5.1 percentage of participants
PREP (Potentially Reduced Exposure Product) GroupQuit Attempts and AbstinenceAny quit attempt, ever within study25.7 percentage of participants
PREP (Potentially Reduced Exposure Product) GroupQuit Attempts and AbstinenceAny 24 h quit attempt, ever within study19.8 percentage of participants
PREP (Potentially Reduced Exposure Product) GroupQuit Attempts and AbstinenceFloating abstinence14.9 percentage of participants
PREP (Potentially Reduced Exposure Product) GroupQuit Attempts and AbstinenceWeek 32 PPA6.2 percentage of participants
Cigarette GroupQuit Attempts and AbstinenceWeek 32 PPA5.6 percentage of participants
Cigarette GroupQuit Attempts and AbstinenceFloating abstinence16.2 percentage of participants
Cigarette GroupQuit Attempts and AbstinenceAny quit attempt, ever within study30.8 percentage of participants
Cigarette GroupQuit Attempts and AbstinenceWeek 58 PPA5.6 percentage of participants
Cigarette GroupQuit Attempts and AbstinenceAny 24 h quit attempt, ever within study25.6 percentage of participants

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026